Amy Michelle Pennington, NP

Amy Pennington practices at Poplar Bluff HMA Physician Management in Poplar Bluff, Missouri.

Amy Pennington's NPI, 1811293756, was assigned on February 9, 2011. Amy Pennington holds Missouri license 2011006223.

Amy Pennington's primary practice is Poplar Bluff HMA Physician Management, at 3098 Oak Grove Rd, Poplar Bluff, MO 63901 in Butler County. The practice phone is (573) 776-2835.

Amy Pennington's primary practice is Poplar Bluff HMA Physician Management in Poplar Bluff, Missouri. Amy Pennington is also affiliated with Poplar Bluff Regional Medical Center. The medical group on file is Regional Physician Services. Dmand AI also links Amy Pennington to 3 more hospitals, 3 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amy Pennington practices, 8 sites in all. Vendor and product names are available with a free account.

Family is Amy Pennington's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Amy Pennington is licensed in Missouri.

CMS counts 189 Medicare patients who saw Amy Pennington in 2024. The largest group is 65 to 74, with 82 patients. 68% of them have high blood pressure, and 63% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Amy Pennington's median patient age at 64, with 58% women.

In 2024, Amy Pennington wrote 8,867 Medicare Part D claims for 406 patients. 85% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Amy Pennington for performance year 2024, reported through an alternative payment model (APM). Amy Pennington accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Amy Pennington as offering telehealth.

CMS Open Payments shows 2 general payments to Amy Pennington from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Averitas Pharma Inc. paid the most, $24.